Auker C.R., Meszler R.M., Carpenter D.O. (1983) Apparent discrepancy between single-unit activity and [14C] deoxyglucose labelling in optic tectum of the rattlesnake. J Neurophysiol49: 1504
Brotchie J.M., Crossman A.R. (1989) Subthalamic efferent transmission in the rat is mediated by an excitatory amino acid. Brit J Pharmacol928P
4.
Brotchie J.B., Mitchell I.J., Crossman A.R.Injections of EAA antagonists in the entopeduncular nucleus of the rat alleviates reserpine-induced akinesia by action at NMDA receptors. Brit J Pharmacol (In Press)
5.
Burns R.S.Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of substantia nigra by N-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine . Proc Natl Acad Sci80: 4546-4550
6.
Carlsson M., Carlsson A. (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm75: 221-226
7.
Carpenter M.B., Whittier J.R., Mettler F.A. (1950) Analysis of choreoid hyperkinesia in the rhesus monkey: surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus of Luys. J Comp Neurol92: 293-331
8.
Carpenter M.B., Batton R.R., Carleton S.C., Keller J.T. (1981a) Interconnections and organization of pallidal and subthalamic nucleus neurons in the monkey. J Comp Neurol197: 579-603.
9.
Carpenter M.B., Carleton S.C., Keller J.T., Conte P. (1981b) Connections of the subthalamic nucleus in the monkey. Brain Res224: 1-29
10.
Carpenter M.B., Sutin J. (1983) Human neuroanatomy, 8th edition. Williams and Wilkins, Baltimore, pp 607-611
11.
Clarke C.E., Sambrook M.A., Mitchell I.J., Crossman A. (1987) Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Neurol Sci78: 273-280
12.
Clarke C.E., Boyce S., Robertson R.G., Sambrook M.A., Crossman A.R. (1989) Drug-induced dyskinesia in primates rendered hemiparkinsonian by the intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Neurol Sci90: 307-314
13.
Classification of extrapyramidal disorders ( 1981) J Neurol Sci51: 311-327
14.
Crossman A.R., Sambrook M.A., Jackson A. (1984) Experimental hemichorea/hemiballismus in the monkey: studies on the intracerebral site of action in a drug-induced dyskinesia. Brain107: 579-596
15.
Crossman A.R., Mitchell I.J., Jackson A.J., Sambrook M.A. (1988) Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex: the site of drug action and a hypothesis of the neural mechanisms of chorea. Brain111: 1211-1233
16.
Cools A.R., Spooren W., Bezemer R., Cuypers E., Jaspers R., Groenewegan H. (1989) Anatomically distinct output channels of the caudate nucleus and orofacial dyskinesia: critical role of the subcommissural part of the globus pallidus in oral dyskinesia. Neuroscience33: 535-542
17.
Cooper I.S. (1969) Involuntary movement disorders. Hoeber Medical Division, Harper and Row, New York
18.
Davis G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., Kopin I.J. (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr Res1: 249-254.
19.
de Veaugh-Geiss J. (1982) Tardive dyskinesia: phenomenology, pathophysiology and pharmacology. In: De Veaugh-Geiss J (ed) Tardive dyskinesia and related involuntary movement disorders . John Wright, London, pp 1-33
20.
DeVito J.L., Anderson M.E. (1982) An autoradiographic study of the efferent connections of the globus pallidus in Macaca mulatta. Exp Brain Res46: 107
21.
Fibiger H.C., Lloyd K.G. (1984) Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. Trends Neurosci7: 462-464
22.
Filion M., Tremblay L., Bedard P.J. (1988) Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res444: 165-176
23.
Fonnom F., Grofova I., Rinvik E. (1978a) Origin and distribution of glutamate decarboxylase in the nucleus subthalamicus of the cat. Brain Res153: 370-374
24.
Fonnum F., Gottesfeld Z., Grofova I. (1978b) Distribution of glutamate decarboxylase, choline acetyltransferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Brain Res143: 125-138
25.
Gunne L.M., Haggstrom J.E., Sjoquist B. (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature309: 347-349.
26.
Ilinsky I.A., Kultas-Ilinsky K. (1987) Sagittal cytoarchitectonic maps of the Macaca mulatta thalamus with a revised numenclature of the motor-related nuclei validated by observations on their connectivity. J Comp Neurol262: 331-364
27.
Kitai S.T., Kita H. ( 1987) Subthalamic neurons and their afferents to the globus pallidus and the substantia nigra in the rat: anatomical and electrophysiological study. In: Carpenter M B, Jayaraman A (eds) Advances in behavioral biology, 32, the basal ganglia II, structure and function - current concepts. Plenum Press, New York, pp 357-378
28.
Klawans H.L. (1973) The pharmacology of extrapyramidal movement disorders , In: Monographs of neural sciences, 2: Basel, Karger
29.
Langston J.W., Ballard P., Tetrad J.W., Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science219: 979-980
30.
Marsden C.D., Parkes J.C. (1976) On-off effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet: 292-296
31.
Marsden C.D., Parkes J.D. (1977) Success and problems of long term therapy in Parkinson's disease. Lancet: 345-349
32.
Mata M., Fink D.J., Gainer H., Smith C.B., Davidsen L., Savaki H., Schwartz W.J., Sokoloff L. (1980) Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem34: 213-215
33.
Miller W.C., Delong M.R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism . In: (Carpenter M B, Jayaraman A (eds) Advances in behavioral biology, 32, the basal ganglia II, structure and function - current concepts. Plenum Press, New York, pp 395-403
34.
Mitchell I.J., Sambrook M.A., Crossman A.R. (1985) Sub-cortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus. Brain108: 405-422
35.
Mitchell I.J., Cross A.J., Sambrook M.A., Crossman A.R. (1986) Neural mechanisms mediating 1-methyl-4-phenyl-l,2,3.6-tetrahydropyridine (MPTP)-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake. Neurosci Letts63: 61-65
36.
Mitchell I.J., Jackson A., Sambrook M.A., Crossman A.R. (1989a) The role of the subthalamic nucleus in experimental chorea: evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies. Brain112: 1533-1548
37.
Mitchell I.J., Clarke C.E., Boyce S., Robertson R.G., Peggs D., Sambrook M.A., Crossman A.R. (1989b) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2 deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience32: 213-226
38.
Mitchell I.J., Page R.D., Robertson R.G., Crossman A.R., Gunne L.M. (1989c) Cerebral 2 deoxyglucose uptake in experimental tardive dyskinesia in the cebus monkey. Brit J Pharmacol98: 938P
39.
Mitchell I.J., Luquin R., Boyce S., Clarke C.E., Robertson R.G., Sambrook M.A., Crossman A.R. (1990) Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia. Movement Dis5: 49-54
40.
Mitchell I.J., Brotchie J.M., Graham W.C., Page R.D., Robertson R.G., Sambrook M.A., Crossman A.R.Advances in the understanding of neural mechanisms in movement disorders . In: Bernardi G, Carpenter M B, Di Chiara G, (eds) The basal ganglia III, Plenum, New York (in press)
41.
Penney J.B., Young A.B. (1981) GABA as the pallidothalamic neurotransmitter: Implications for basal ganglia function. Brain Res207: 195-199
42.
Perkins M.N., Stone T.W. (1980) Subthalamic projections to the globus pallidus: an electrophysiological study in the rat. Exp Neurol68: 500-511
43.
Perkins M.N., Stone T.W. (1981) Iontophoretic studies on pallidal neurones and the projection from the subthalamic nucleus. Q J Exp Physiol66: 225-236
44.
Robertson R.G., Farmery S.M., Sambrook M.A., Crossman A.R. (1989) Dyskinesia in the primate following injection of an excitatory amino acid antagonist int the medial segment of the globus pallidus . Brain Res476: 317-322
45.
Rouzaire-Dubois B., Hammond C., Hamon B., Feger J. (1980) Pharmacological blockade of the globus pallidus-induced inhibitory response of subthalamic cells in the rat. Brain Res200: 321-329
46.
Rouzaire-Dubois B., Scarnati E., Hammond C., Crossman A.R., Shibazaki T. (1983) Microiontophoretic studies on the nature of the neurotransmitter in the subthalamo-entopeduncular pathway of the rat. Brain Res271: 11-20
47.
Schnieder J.S. (1989) Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent to nigrostriatal damage. Pharm Biochem Behav34: 193-196
48.
Schwartz W.J., Smith C.B., Davidsen L., Savaki H., Sokoloff L. (1979) Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science205: 723-725
49.
Simpson G.M., Kline N.S. (1976) Tardive dyskinesia: manifestations, incidence, etiology, and treatment. In: Yahr M (ed) The basal gangliaRaven Press, New York, pp 427-432
50.
Smithy Y., Parent A. (1988) Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res453: 353-356
51.
Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlack C.S., Pettigrew K.D., Sakurada O., Shinohara M. (1977) The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem28: 897-916.
52.
Walton J (ed) (1985) Brain's diseases of the nervous system. Oxford University Press , Oxford.
53.
Whittier J.R. (1947) Ballism and the subthalamic nucleus (nucleus hypothalamicus; corpus Luysi. Arch Neurol Psychiat58: 672-692
